← Back to Search
Mind-Body Skills Training for Mood Symptoms
White Plains, NY
N/A
Recruiting
Led By Patricia Marino, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18 or older
Be older than 18 years old
Must not have
Current mania
Active suicidal ideation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 0, week 9 and week 13
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a program that teaches meditation, mindfulness, and relaxation techniques to help medical graduate students manage stress and improve their mood.
See full description
Who is the study for?
This trial is for graduate and medical students aged 18 or older who are experiencing mood symptoms like anxiety or depression. Participants must be able to attend weekly sessions and have a score of ≥4 on the Generalized Anxiety Disorder scale. Those with active suicidal thoughts, current mania, or psychosis cannot join.Check my eligibility
What is being tested?
The study tests an 8-week Integrative-Mind-Body Skills Group (I-MBS-G) program designed to improve mood management through meditation, mindfulness, guided imagery, breath work, body awareness, and relaxation techniques.See study design
What are the potential side effects?
While not explicitly stated in the provided information, mind-body interventions may sometimes lead to increased emotional sensitivity or discomfort as individuals confront stressful issues during practice.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
show original
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently experiencing a manic episode.
show original
Select...
I am currently having thoughts about harming myself.
show original
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 0, week 9 and week 13
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 0, week 9 and week 13
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
The Integrative-Mind-Body Skills Group program evaluation measures the acceptability of the Integrative-Mind-Body Skills Group Program.
The Integrative-Mind-Body Skills Group program evaluation measures the feasibility of the Integrative-Mind-Body Skills Group Program.
Secondary study objectives
Change from Baseline (week 0) in Anxiety symptoms as measured in the Generalized Anxiety Disorder (GAD-7) at Weeks 9 and 13.
Other study objectives
Change from Baseline (week 0) in Depressive symptoms as measured on the Patient Health Questionnaire (PHQ-9) at Weeks 9 and 13.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Integrative-Mind-Body Skills GroupExperimental Treatment1 Intervention
Treatment group
Group II: ControlActive Control1 Intervention
Control group: Treatment-As-Usual (TAU) and mind-body skills reading materials.
Find a Location
Closest Location:Weill Cornell Medical College· White Plains, NY
Who is running the clinical trial?
Weill Medical College of Cornell UniversityLead Sponsor
1,101 Previous Clinical Trials
1,156,941 Total Patients Enrolled
69 Trials studying Depression
16,695 Patients Enrolled for Depression
Patricia Marino, PhDPrincipal InvestigatorWeill Medical College of Cornell University
2 Previous Clinical Trials
65 Total Patients Enrolled
2 Trials studying Depression
65 Patients Enrolled for Depression
Suza C Scalora, PhDPrincipal InvestigatorWeill Medical College of Cornell University
Media Library
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.